Literature DB >> 19571705

Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?

Rodrigo O Perez1, Diego D Pereira, Igor Proscurshim, Joaquim Gama-Rodrigues, Viviane Rawet, Guilherme P São Julião, Desiderio Kiss, Ivan Cecconello, Angelita Habr-Gama.   

Abstract

OBJECTIVES: Local excision is currently being considered as an alternative strategy for ypT0-2 rectal cancer. However, patient selection is crucial to rule out nodal disease and is performed by radiologic studies that consider size as a surrogate marker for positive nodes. The purpose of this study was to determine the difference in size between metastatic and nonmetastatic nodes and the critical lymph node size after neoadjuvant chemoradiation therapy.
METHODS: The 201 lymph nodes available from 31 patients with ypT0-2 rectal cancer were reviewed and measured. Lymph nodes were compared according to the presence of metastases and size.
RESULTS: There was a mean of 6.5 lymph nodes per patient and 12 positive nodes of the 201 recovered (6%). Ninety-five percent of all lymph nodes were <5 mm, whereas 50% of positive lymph nodes were <3 mm. Metastatic lymph nodes were significantly greater in size (5.0 vs. 2.5mm; P = 0.02). Lymph nodes >4.5 mm had a greater risk of harboring metastases (P = 0.009).
CONCLUSIONS: Patients with ypT0-2 rectal cancer following neoadjuvant chemoradiation have very small perirectal nodes. Individual metastatic lymph nodes are significantly larger. However, a significant number of lymph nodes after neoadjuvant chemoradiation (negative and positive) are <3 mm. Individual lymph node size is not a good predictor of nodal metastases and may lead to inaccurate radiologic staging.

Entities:  

Mesh:

Year:  2009        PMID: 19571705     DOI: 10.1007/DCR.0b013e3181a0af4b

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

1.  Number of lymph nodes after neoadjuvant therapy for rectal cancer: How many are needed?

Authors:  Stefano Scabini; Valter Ferrando
Journal:  World J Gastrointest Surg       Date:  2012-02-27

2.  Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Authors:  Anthony T Ruys; Fiebo J W Ten Kate; Olivier R Busch; Marc R Engelbrecht; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

3.  What is the pelvic lymph node normal size? Determination from normal MRI examinations.

Authors:  Marjorie Ramirez; Pierre Ingrand; Jean-Pierre Richer; Guillaume Herpe; Guillaume Vesselle; Samy Boucebci; Jean-Pierre Tasu
Journal:  Surg Radiol Anat       Date:  2015-10-29       Impact factor: 1.246

Review 4.  Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 5.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].

Authors:  T Sprenger; H Rothe; T Beissbarth; L-C Conradi; A Kauffels; K Homayounfar; C L Behnes; C Rödel; T Liersch; M Ghadimi
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

7.  The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy.

Authors:  Im-Kyung Kim; Jeonghyun Kang; Beom Jin Lim; Seung-Kook Sohn; Kang Young Lee
Journal:  Int J Colorectal Dis       Date:  2015-01-15       Impact factor: 2.571

Review 8.  Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging.

Authors:  Tyler J Fraum; Joseph W Owen; Kathryn J Fowler
Journal:  Clin Colon Rectal Surg       Date:  2016-09

9.  Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?

Authors:  Luc A Heijnen; Doenja M J Lambregts; Milou H Martens; Monique Maas; Frans C H Bakers; Vincent C Cappendijk; Pedro Oliveira; Guido Lammering; Robert G Riedl; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2013-09-20       Impact factor: 5.315

10.  Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

Authors:  Thilo Sprenger; Hilka Rothe; Kia Homayounfar; Tim Beissbarth; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  J Gastrointest Surg       Date:  2009-10-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.